Population
Human or mouse serum, adiponectin expressed in NIH-3T3 or Escherichia coli, and hepatocytes
Comparison
Human adiponectin mutations vs Wild-type adiponectin
Design
Preclinical
Authors
Loading...
Impaired adiponectin multimerization may underlie hypoadiponectinemia in diabetes; animal data leave open human validation and therapeutic relevance.
Adiponectin mutations associated with diabetes and hypoadiponectinemia cause impaired multimerization and/or secretion, highlighting the importance of multimer distribution in interpreting plasma adiponectin levels.
Waki et al. (2003) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: